Prehypertension: Clinical Trials

11 trials for Prehypertension, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 2 unknown, 1 recruiting. 11 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 311Completed 8, Unknown 2, Recruiting 1
Phase 22Completed 2

Follow Prehypertension: new trials by email Literature Review of Prehypertension trials Research Report on Prehypertension

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Orforglipron, Placebo - Overweight, Prediabetic State
Phase 3RecruitingEli Lilly and Company20012026-08-262026-11-05
Technology for Innovative Monitoring of Cardiovascular Prevention: a RCT
TELEM, TELEMEV, TELEM-TELEMEV - Blood Pressure, High, Prehypertension
Phase 3UnknownHospital de Clinicas de Porto Alegre2312017-01-012018-04-26
Center of Research Translation (CORT) Project 2
Allopurinol, Placebo - Pre-hypertension, JNC 7 Stage I Hypertension
Phase 2 / Phase 3CompletedUniversity of Alabama at Birmingham992014-07-012021-01-11
Impact of Periodontal Intervention on Vascular Dysfunction
One-Stage Full-Mouth Disinfection, Periodontal care - Chronic Periodontitis, Prehypertension
Phase 3CompletedFirst Affiliated Hospital, Sun Yat-Sen University1232012-12-012015-04-17
Effects and Safety of Taurine Granule on Blood Pressure in Prehypertensive
Taurine granule, Placebo - Prehypertension
Phase 3CompletedZhiming Zhu1202012-12-012015-11-24
Effects and Safety of Menthol on Blood Pressure and Metabolic Parameters in Prehypertensive and Mild Hypertensive Patients
Menthol, Placebo - Hypertension, Prehypertension
Phase 2 / Phase 3CompletedZhiming Zhu362012-08-012020-03-11
The Effects of Polyphenol-rich Berry Juice on Blood Pressure in Hypertensive Subjects
Placebo, Mana-juice, Optijuice - Pre-hypertension, Hypertension
Phase 3CompletedUniversity of Oslo1532011-12-012012-07-03
Blood Pressure Lowering Effect of Supplementation With Korea Red Ginseng Associated With Reductions in Circulating Lp-PLA2 Activity and Lysophospatidylcholines and an Increase in Dihydrobiopterin in Prehypertensive Subjects
KRG, Placebo - Prehypertension
Phase 3CompletedYonsei University622011-11-012014-12-29
Effect of Ginseol Kg1 on Blood Pressure Lowering
Ginseol Kg1 (low dose), Ginseol Kg1(high dose), Placebo - Prehypertension, Hypertension, Stage I
Phase 3UnknownSeoul National University Hospital902011-09-012011-12-02
Hypertension Prevention in Pre-Hypertensive Individuals
Chlorthalidone plus amiloride, placebo - Pre-hypertension, Hypertension
Phase 3CompletedHospital de Clinicas de Porto Alegre7302010-07-012015-02-12
Salt Reduction on Blood Pressure and Cardiovascular Organ Damage
Reduce salt intake - Hypertension
Phase 3CompletedSt George's, University of London2102004-04-012015-06-09

Narrower conditions

Hypertension (7)  ·  Cardiovascular Diseases (1)  ·  Chronic Periodontitis (1)  ·  Obesity, Abdominal (1)  ·  Overweight (1)  ·  Periodontitis (1)  ·  Prediabetic State (1)

Broader conditions

Vascular Diseases (11)  ·  Cardiovascular Diseases (10)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Body Weight (1)  ·  Chronic Disease (1)  ·  Diabetes Mellitus (1)  ·  Disease Attributes (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Mouth Diseases (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Obesity (1)  ·  Overnutrition (1)

Interventions

Allopurinol (1)  ·  Amiloride (1)  ·  Chlorthalidone (1)  ·  Diuretics (1)  ·  Menthol (1)  ·  orforglipron (1)

Sponsors

Hospital de Clinicas de Porto Alegre (2)  ·  Zhiming Zhu (2)  ·  Eli Lilly and Company (1)  ·  First Affiliated Hospital, Sun Yat-Sen University (1)  ·  Seoul National University Hospital (1)  ·  St George's, University of London (1)  ·  University of Alabama at Birmingham (1)  ·  University of Oslo (1)  ·  Yonsei University (1)

Countries

China (4)  ·  Brazil (2)  ·  South Korea (2)  ·  United States (2)  ·  Argentina (1)  ·  Czechia (1)  ·  Germany (1)  ·  India (1)  ·  Japan (1)  ·  Mexico (1)  ·  Norway (1)  ·  Puerto Rico (1)  ·  Spain (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

Graham A MacGregor, MD (1)  ·  Jun Tao, M.D.,phD. (1)  ·  Jun Ying Yang, Master (1)  ·  Kwang-il Kim, MD, PhD (1)  ·  Rune Blomhoff, PhD (1)  ·  Sandra C Fuchs (1)  ·  Sandra C Fuchs, MD, PhD (1)

Results publications

PMID 24637663, PMID 24871654, PMID 26843120, PMID 27965209, PMID 28452620, PMID 29227377, PMID 30087093, PMID 31079530, PMID 32475312, PMID 33779064, PMID 34493347, PMID 37107903

NIH funding

P50AR060772 (1)